A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Cancer Research

• Publication date

  2001-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11306463
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Retinoblastoma Protein and Cell Cycle Control Review

  2004cited by this paper
• Defining the substrate specificity of cdk4 kinase-cyclin D1 complex.

  1999cited by this paper
• Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists.

  1999cited by this paper
• Tossing monkey wrenches into the clock: new ways of treating cancer.

  1999cited by this paper
• A p21(Waf1/Cip1)carboxyl-terminal peptide exhibited cyclin-dependent kinase-inhibitory activity and cytotoxicity when introduced into human cells.

  1999cited by this paper
• Analysis of site-specific phosphorylation of the retinoblastoma protein during cell cycle progression.

  1999cited by this paper
• Interaction between cyclin-dependent kinases and human papillomavirus replication-initiation protein E1 is required for efficient viral replication.

  1999cited by this paper
• Retinoblastoma Protein Contains a C-terminal Motif That Targets It for Phosphorylation by Cyclin-cdk Complexes

  1999influential reference
• CDK inhibitors: positive and negative regulators of G1-phase progression.

  1999cited by this paper
• Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7

  1998influential reference
• Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth

  1998cited by this paper
• Defining the minimal portion of the retinoblastoma protein that serves as an efficient substrate for cdk4 kinase/cyclin D1 complex.

  1998cited by this paper
• Functional Inactivation of the Retinoblastoma Protein Requires Sequential Modification by at Least Two Distinct Cyclin-cdk Complexes

  1998cited by this paper
• Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A.

  1998cited by this paper
• The retinoblastoma gene family: cousins with overlapping interests.

  1998influential reference
• Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma.

  1997cited by this paper
• Monoclonal antibodies specific for underphosphorylated retinoblastoma protein identify a cell cycle regulated phosphorylation site targeted by CDKs

  1997cited by this paper
• Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation.

  1997cited by this paper
• RB kinases and RB-binding proteins: new points of view.

  1997cited by this paper
• The consensus motif for phosphorylation by cyclin D1‐Cdk4 is different from that for phosphorylation by cyclin A/E‐Cdk2.

  1996cited by this paper
• Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex

  1996cited by this paper
• Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis.

  1996cited by this paper
• Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.

  1996cited by this paper
• Regulation of the retinoblastoma protein-related protein p107 by G1 cyclin-associated kinases.

  1996cited by this paper
• G1 cyclins control the retinoblastoma gene product growth regulation activity via upstream mechanisms.

  1995cited by this paper
• Interaction between the retinoblastoma protein and the oncoprotein MDM2

  1995cited by this paper
• p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F.

  1995cited by this paper
• Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes.

  1995cited by this paper
• The retinoblastoma protein and cell cycle control.

  1995cited by this paper
• The retinoblastoma tumor suppressor protein.

  1994cited by this paper
• D-type cyclin-dependent kinase activity in mammalian cells

  1994cited by this paper
• A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle.

  1993cited by this paper
• Physical interaction of the retinoblastoma protein with human D cyclins.

  1993cited by this paper
• Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain.

  1993cited by this paper
• Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4.

  1993cited by this paper
• Functional interactions of the retinoblastoma protein with mammalian D-type cyclins.

  1993cited by this paper
• Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins.

  1992cited by this paper
• Biological function of the retinoblastoma protein requires distinct domains for hyperphosphorylation and transcription factor binding

  1992influential reference
• Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein.

  1991cited by this paper
• The retinoblastoma protein is phosphorylated on multiple sites by human cdc2.

  1991cited by this paper
• Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product.

  1989cited by this paper
• The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product.

  1989cited by this paper
• The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus.

  1989cited by this paper
• SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene.

  1988cited by this paper
• Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product

  1988cited by this paper
• Differential distribution of the adenovirus E1A proteins and colocalization of E1A with the 70-kilodalton cellular heat shock protein in infected cells

  1988cited by this paper

• Novel CDK2/CDK9 inhibitor fadraciclib targets cell survival and DNA damage pathways and synergizes with encorafenib in human colorectal cancer cells with BRAF(V600E)

  2025cites this paper
• RB functions as a key regulator of senescence and tumor suppression.

  2024cites this paper
• Commiphora myrrha n-hexane extract suppressed breast cancer progression through induction of G0/G1 phase arrest and apoptotic cell death by inhibiting the Cyclin D1/CDK4-Rb signaling pathway

  2024cites this paper
• GSG2 facilitates the progression of human breast cancer through MDM2-mediated ubiquitination of E2F1

  2023cites this paper
• Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma

  2022cites this paper
• Translocation of nuclear chromatin distribution to the periphery reflects dephosphorylated threonine-821/826 of the retinoblastoma protein (pRb) in T24 cells treated with Bacillus Calmette–Guérin

  2022cites this paper
• Changes in Cyclin D1, cdk4, and Their Associated Molecules in Ischemic Pyramidal Neurons in Gerbil Hippocampus after Transient Ischemia and Neuroprotective Effects of Ischemic Preconditioning by Keeping the Molecules in the Ischemic Neurons

  2021cites this paper
• Mechanistic Insights Into DREAM and RB Control of the Cell Cycle

  2019influential citation
• p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition

  2019cites this paper
• Correlation between the protein expression levels of A‐kinase anchor protein95, p‐retinoblastoma (Ser780), cyclin D2/3, and cyclin E2 in esophageal cancer tissues

  2019cites this paper
• Cyclin D-Cdk4,6 drives cell cycle progression via the retinoblastoma protein’s C-terminal helix

  2018cites this paper
• PRMT5 competitively binds to CDK4 to promote G1-S transition upon glucose induction in hepatocellular carcinoma

  2016cites this paper
• Characterising the phosphorylation of YB-1

  2015influential citation
• SYNTHETIC LETHALITY OF CDK INHIBITION AND DOXORUBICIN IN TRIPLE-NEGATIVE BREAST CANCER REQUIRES P53 INACTIVATION

  2015influential citation
• A Novel Retinoblastoma Protein (RB) E3 Ubiquitin Ligase (NRBE3) Promotes RB Degradation and Is Transcriptionally Regulated by E2F1 Transcription Factor*

  2015cites this paper
• Identification of intrinsically disordered regions in PTEN and delineation of its function via a network approach.

  2015cites this paper
• PP2A: more than a reset switch to activate pRB proteins during the cell cycle and in response to signaling cues

  2014cites this paper
• Manganese Superoxide Dismutase Regulates a Redox Cycle Within the Cell Cycle

  2014cites this paper
• LIMD1 antagonizes E2F1 activity and cell cycle progression by enhancing Rb function in cancer cells

  2014cites this paper
• Deciphering the retinoblastoma protein phosphorylation code.

  2013cites this paper
• This information is current as Activity in T Cells Responding to IL-2 S-Phase Entry and Maintains S6 Kinase Protein/Caspase-8-Signaling Axis Promotes A Fas-Associated Death Domain

  2013cites this paper
• Molecular mechanisms underlying RB protein function

  2013cites this paper
• unique molecular profile for light chain amyloidosis Functional gene expression analysis of clonal plasma cells identifies a

  2013cites this paper
• Cyclin-dependent kinase 5 regulates E2F transcription factor through phosphorylation of Rb protein in neurons

  2012cites this paper
• Depletion of SUMO ligase hMMS21 impairs G1 to S transition in MCF-7 breast cancer cells.

  2012cites this paper
• The Cyclin-Dependent Kinase Inhibitor SCH 727965 (Dinacliclib) Induces the Apoptosis of Osteosarcoma Cells

  2011cites this paper
• Effects of an Indolocarbazole-Derived CDK4 Inhibitor on Breast Cancer Cells

  2011cites this paper
• Incomplete Folding upon Binding Mediates Cdk4/Cyclin D Complex Activation by Tyrosine Phosphorylation of Inhibitor p27 Protein*

  2011cites this paper
• Cell Cycle Deregulation in Ewing's Sarcoma Pathogenesis

  2010cites this paper
• JC Virus Small t Antigen Binds Phosphatase PP2A and Rb Family Proteins and Is Required for Efficient Viral DNA Replication Activity

  2010cites this paper
• Smad2/3 is involved in growth inhibition of mouse embryonic palate mesenchymal cells induced by all-trans retinoic acid.

  2009cites this paper
• Crystal structure of human CDK4 in complex with a D-type cyclin

  2009cites this paper
• Low-penetrant RB allele in small-cell cancer shows geldanamycin instability and discordant expression with mutant ras

  2008cites this paper
• A redox cycle within the cell cycle: ring in the old with the new

  2007cites this paper
• A Fas-Associated Death Domain Protein/Caspase-8-Signaling Axis Promotes S-Phase Entry and Maintains S6 Kinase Activity in T Cells Responding to IL-21

  2007cites this paper
• PDGF-C controls proliferation and is down-regulated by retinoic acid in mouse embryonic palatal mesenchymal cells.

  2006cites this paper
• Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release.

  2005influential citation
• Functional gene expression analysis of clonal plasma cells identifies a unique molecular profile for light chain amyloidosis.

  2005cites this paper
• Abnormal expression of Rb pathway-related proteins in salivary gland acinic cell carcinoma.

  2005cites this paper
• Construction of a Cyclin D1-Cdk2 Fusion Protein to Model the Biological Functions of Cyclin D1-Cdk2 Complexes*

  2004cites this paper
• Geldanamycin, an inhibitor of the chaperone activity of HSP90, induces MAPK‐independent cell cycle arrest

  2004cites this paper
• Induction of cell-cycle arrest by all-trans retinoic acid in mouse embryonic palatal mesenchymal (MEPM) cells.

  2004cites this paper
• Docking-Dependent Regulation of the Rb Tumor Suppressor Protein by Cdk4

  2004cites this paper
• The discovery of a new structural class of cyclin-dependent kinase inhibitors, aminoimidazo[1,2-a]pyridines.

  2004cites this paper
• Distinct Mechanisms for Regulating the Tumor Suppressor and Antiapoptotic Functions of Rb*

  2003cites this paper
• Sp1 Inhibits Proliferation and Induces Apoptosis in Vascular Smooth Muscle Cells by Repressing p21WAF1/Cip1 Transcription and Cyclin D1-Cdk4-p21WAF1/Cip1 Complex Formation*

  2003cites this paper
• Inhibition of Retinoblastoma Protein Degradation by Interaction with the Serpin Plasminogen Activator Inhibitor 2 via a Novel Consensus Motif

  2003cites this paper
• Physical interaction between pRb and cdk9/cyclinT2 complex

  2002cites this paper
• New insight in cdk9 function: from Tat to MyoD.

  2001cites this paper